跳至主要内容
临床试验/NCT07128368
NCT07128368尚未招募不适用

Mechanisms of Resistance Exercise Training for Improved Muscle Insulin Sensitivity

Mayo Clinic1 个研究点 分布在 1 个国家目标入组 16 人开始时间: 2026年9月1日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
尚未招募
发起方
Mayo Clinic
入组人数
16
试验地点
1
主要终点
Change in muscle protein synthesis

研究概览

简要总结

To uncover the underlying mechanisms of resistance exercise training benefits on glucose metabolism and insulin sensitivity in muscle.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Basic Science
盲法
None

入排标准

年龄范围
30 Years 至 50 Years(Adult)
性别
All
接受健康志愿者
是

入选标准

  • •Sedentary (≤30min of physical activity on ≤1 day/week)
  • •Weight stable for ≥3 months prior to study

排除标准

  • •Active coronary artery disease or heart failure.
  • •Participation in a structured exercise program > 1 day/week.
  • •A known medical condition that in the judgment of the investigator might interfere with the completion of the protocol such as the following examples:
  • •Abnormal liver function test results (Transaminase >2 times the upper limit of normal)
  • •Abnormal renal function test results (calculated GFR <60 mL/min/1.73m2); If on antihypertensive, thyroid, anti-depressant or lipid lowering medication, lack of stability on the medication for the past 2 months prior to enrollment in the study
  • •Uncontrolled thyroid disease (TSH undetectable or >10 mlU/L); testing required within three months prior to admission for subjects with a goiter, positive antibodies, or who are on thyroid hormone replacement, and within one year otherwise
  • •Abuse of alcohol or recreational drugs
  • •Active tobacco usage
  • •Infectious process not anticipated to resolve prior to study procedures (e.g. meningitis, pneumonia, osteomyelitis).
  • •Uncontrolled arterial hypertension (Resting diastolic blood pressure >90 mmHg and/or systolic blood pressure >160 mmHg) at the time of screening.
  • •A recent injury to body or limb, muscular disorder, use of any medication, any carcinogenic disease, or other significant medical disorder if that injury, medication or disease in the judgment of the investigator will affect the completion of the protocol
  • •Active pregnancy
  • •Menopause (defined as absence of menstruation for 12 consecutive months)
  • •Restrictions on Use of Other Drugs or Treatments:
  • •Any other medication believed to be a contraindication to the subject's participation.

研究组 & 干预措施

Resistance Exercise Training

Experimental

干预措施: Resistance Exercise Training (Other)

结局指标

主要结局

Change in muscle protein synthesis

时间窗: Baseline; 8 weeks

Rate of insulin-stimulated synthesis of individual proteins

次要结局

未报告次要终点

研究者

发起方
Mayo Clinic
申办方类型
Other
责任方
Principal Investigator
主要研究者

Mark Pataky

Associate Consultant I Endocrinology, Diabetes and Metabolism

Mayo Clinic

研究点 (1)

Loading locations...

相似试验